NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1-Reference-Cited by-同舟云学术

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1

Published:2007-06 Issue:25 Volume:282 Page:18245-18253
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Yamashita Teruhito,Yao Zhenqiang,Li Fang,Zhang Qian,Badell I. Raul,Schwarz Edward M.,Takeshita Sunao,Wagner Erwin F.,Noda Masaki,Matsuo Koichi,Xing Lianping,Boyce Brendan F.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference73 articles.

1. Osteoclast differentiation and activation

2. Osteoclasts, integrins, and osteoporosis

3. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

4. RANK is essential for osteoclast and lymph node development

5. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causal relationship between circulating levels of cytokines and bone mineral density: A mendelian randomization study;Cytokine;2024-10

2. Senoinflammation as the underlying mechanism of aging and its modulation by calorie restriction;Ageing Research Reviews;2024-09

3. Exploring the Role of Hormones and Cytokines in Osteoporosis Development;Biomedicines;2024-08-12

4. 6-O-angeloylplenolin inhibits osteoclastogenesis in vitro via suppressing c-Src/NF-κB/NFATc1 pathways and ameliorates bone resorption in collagen-induced arthritis mouse model;Biochemical Pharmacology;2024-06

5. Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology;Frontiers in Immunology;2024-05-16